CSL Ltd (CSJ MU) stock market data APIs
€138.3076
0(0%)
as of July 15, 2025
Try our APIs with
free plan!
CSL Ltd Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for CSJ.MU.
Prev. Close
138.3076
Open
138.3076
High
138.3076
Low
138.3076
52 wk Range
126.86-188.2642
Market Cap
86 015 M
Dividends (Yield)
0.0082
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CSL Ltd data using free add-ons & libraries
Get CSL Ltd Fundamental Data
CSL Ltd Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CSL Ltd News
New
Australian biotech CSL to trim R&D division, rely on external partnerships
(Reuters) -Australian biotech giant CSL Ltd said on Tuesday it plans to trim its research and development division across six global locations and would rely more on external partnerships, a move that...
ALKS or CSLLY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Alkermes (ALKS) and CSL Limited Sponsored ADR (CSLLY). But which of these two stocks pre...
Is There An Opportunity With CSL Limited's (ASX:CSL) 39% Undervaluation?
Key Insights The projected fair value for CSL is AU$391 based on 2 Stage Free Cash Flow to Equity Current share price of AU$239 suggests CSL is potentially 39% undervalued Analyst price target for CS...
U.S. Food and Drug Administration Approves CSL's ANDEMBRY® (garadacimab-gxii), the Only Prophylactic Hereditary Angioedema (HAE) Treatment Targeting Factor XIIa with Once-Monthly Dosing for All Patients From the Start
ANDEMBRY inhibits the top of the HAE cascade by targeting factor XIIa and provides sustained protection from attacks Once-monthly dosing reduced HAE attacks by a median of more than 99 percent and a l...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
